Sartorius (OTCMKTS:SARTF) Shares Gap Up – Should You Buy?

Sartorius (OTCMKTS:SARTF – Get Free Report)’s stock price gapped up before the market opened on Monday . The stock had previously closed at $212.80, but opened at $227.16. Sartorius shares last traded at $227.16, with a volume of 5 shares changing hands.

Sartorius Stock Up 7.4%

The company has a debt-to-equity ratio of 0.89, a current ratio of 0.95 and a quick ratio of 0.49. The stock has a market capitalization of $8.35 billion, a PE ratio of 113.42 and a beta of 0.98. The company has a 50 day moving average price of $214.01 and a 200-day moving average price of $216.47.

Sartorius Company Profile

(Get Free Report)

Sartorius AG is a Germany-based life science company that develops and supplies equipment, technologies and services for pharmaceutical, biotechnology and laboratory applications. Its offerings support the development, production and quality control of medicines, vaccines and other biological products.

The company’s products include laboratory instruments, balances, filtration systems, laboratory consumables, bioreactors, cell-culture technologies, fluid-management systems, sensors and analytical equipment.

Read More

• Five stocks we like better than Sartorius
• Meta’s Muse Highlights Arm’s Growing Role in AI Infrastructure
• Oura’s $15.6 Billion IPO Is Betting Investors See More Than a Smart Ring
• AMD Chips Away at NVIDIA’s AI Throne
• Is the Fed Playing Chess With Rates—Or Just Behind the Curve Again?